NZ552027A - Compositions and methods for the management of hyperproliferative dermatological conditions - Google Patents
Compositions and methods for the management of hyperproliferative dermatological conditionsInfo
- Publication number
- NZ552027A NZ552027A NZ552027A NZ55202704A NZ552027A NZ 552027 A NZ552027 A NZ 552027A NZ 552027 A NZ552027 A NZ 552027A NZ 55202704 A NZ55202704 A NZ 55202704A NZ 552027 A NZ552027 A NZ 552027A
- Authority
- NZ
- New Zealand
- Prior art keywords
- bosweliic
- psoriasis
- medicament
- beta
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/710,778 US7582314B2 (en) | 2003-12-03 | 2004-08-02 | Compositions and methods for the management of hyperproliferative dermatological conditions |
| PCT/US2004/033846 WO2006022762A1 (en) | 2004-08-02 | 2004-10-14 | Compositions and methods for the management of hyperproliferative dermatological conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ552027A true NZ552027A (en) | 2009-10-30 |
Family
ID=35967805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ552027A NZ552027A (en) | 2004-08-02 | 2004-10-14 | Compositions and methods for the management of hyperproliferative dermatological conditions |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1791423B1 (enExample) |
| JP (1) | JP4820819B2 (enExample) |
| CN (1) | CN101132693B (enExample) |
| AU (1) | AU2004322710B2 (enExample) |
| DK (1) | DK1791423T3 (enExample) |
| ES (1) | ES2422893T3 (enExample) |
| NZ (1) | NZ552027A (enExample) |
| PL (1) | PL1791423T3 (enExample) |
| PT (1) | PT1791423E (enExample) |
| RU (1) | RU2366412C2 (enExample) |
| WO (1) | WO2006022762A1 (enExample) |
| ZA (1) | ZA200700694B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010029578A2 (en) * | 2008-09-15 | 2010-03-18 | Ganga Raju Gokaraju | Synergistic anti-inflammatory compositions comprising boswellia serrata extracts |
| ITVR20080125A1 (it) * | 2008-11-13 | 2010-05-14 | Phytonature Sas Di Masini Dr Antoni O E C | Nuova forma di preparazione ed utilizzo della boswellia serrata |
| WO2011099029A1 (en) * | 2010-02-15 | 2011-08-18 | Laila Nutraceuticals | A novel boswellia low polar gum resin extract and its synergistic compositions |
| US20110218172A1 (en) * | 2010-03-02 | 2011-09-08 | Muhammed Majeed | Composition for down-regulating pro-inflammatory markers |
| CN102670565A (zh) * | 2011-03-14 | 2012-09-19 | 苏州博创园生物医药科技有限公司 | 一种含天然药物的透皮吸收贴片 |
| CN102670690A (zh) * | 2011-03-14 | 2012-09-19 | 苏州博创园生物医药科技有限公司 | 一种抗牛皮癣纯天然药物乳膏及其制备方法 |
| CN103193853A (zh) * | 2012-01-06 | 2013-07-10 | 苏州博创园生物医药科技有限公司 | 用于治疗银屑病的化合物、组合物及其制备方法 |
| US9498423B2 (en) * | 2012-05-07 | 2016-11-22 | Sami Labs Limited | Synergistic selenopeptide formulations for the protection of dermal papilla cells |
| CA3020713A1 (en) * | 2016-04-19 | 2017-10-26 | Azura Ophthalmics Ltd. | Compositions for the treatment of hyperkeratosis disorders |
| US9975917B1 (en) | 2017-09-20 | 2018-05-22 | King Saud University | Pentacyclic triterpenoidal derivatives |
| EP4087655A4 (en) | 2020-01-10 | 2024-02-21 | Azura Ophthalmics Ltd | INSTRUCTIONS FOR COMPOSITION AND SENSITIVITY |
| EP4295842A1 (en) | 2022-06-24 | 2023-12-27 | Faaborg Pharma - IP ApS | A skin care composition |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3670084A (en) * | 1969-06-20 | 1972-06-13 | Leopoldo F Montes | Method of treating psoriasis with cycloheximide |
| DE4201903B4 (de) * | 1992-01-24 | 2004-04-15 | Hermann P.T. Prof. Dr.Med. Ammon | Pharmazeutische Verwendung von Boswelliasäuren |
| DE4445728A1 (de) * | 1994-12-21 | 1996-06-27 | Simmet Th Prof Dr | Verwendung von Boswelliasäure zur Behandlung von Hirntumoren |
| US5536506A (en) * | 1995-02-24 | 1996-07-16 | Sabinsa Corporation | Use of piperine to increase the bioavailability of nutritional compounds |
| RU2152218C1 (ru) * | 1998-04-21 | 2000-07-10 | Дальневосточный государственный медицинский университет | Способ лечения псориаза |
| CN1064264C (zh) * | 1998-04-28 | 2001-04-11 | 山东省滨州卫生学校 | 富硒灵芝在制备治疗银屑病的药物中的应用 |
| US6399105B1 (en) * | 1999-01-20 | 2002-06-04 | Peter Donald Collin | Sea cucumber carotenoid lipid fraction products and methods of use |
| EP1173162A1 (en) * | 1999-04-30 | 2002-01-23 | Sabinsa Corporation | Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
| CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
| GB0230203D0 (en) * | 2002-12-27 | 2003-02-05 | Domantis Ltd | Fc fusion |
| KR20050090435A (ko) * | 2002-12-30 | 2005-09-13 | 셀진 코포레이션 | 플루오로알콕시-치환된 1,3-디히드로-이소인돌릴 화합물 및그의 제약학적 용도 |
-
2004
- 2004-10-14 WO PCT/US2004/033846 patent/WO2006022762A1/en not_active Ceased
- 2004-10-14 RU RU2007102720/14A patent/RU2366412C2/ru active
- 2004-10-14 AU AU2004322710A patent/AU2004322710B2/en not_active Ceased
- 2004-10-14 PT PT47950605T patent/PT1791423E/pt unknown
- 2004-10-14 EP EP04795060.5A patent/EP1791423B1/en not_active Expired - Lifetime
- 2004-10-14 JP JP2007524780A patent/JP4820819B2/ja not_active Expired - Fee Related
- 2004-10-14 ES ES04795060T patent/ES2422893T3/es not_active Expired - Lifetime
- 2004-10-14 CN CN2004800436759A patent/CN101132693B/zh not_active Expired - Fee Related
- 2004-10-14 PL PL04795060T patent/PL1791423T3/pl unknown
- 2004-10-14 DK DK04795060.5T patent/DK1791423T3/da active
- 2004-10-14 NZ NZ552027A patent/NZ552027A/en not_active IP Right Cessation
-
2007
- 2007-01-25 ZA ZA200700694A patent/ZA200700694B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2007102720A (ru) | 2008-09-10 |
| DK1791423T3 (da) | 2013-08-05 |
| WO2006022762B1 (en) | 2006-05-04 |
| RU2366412C2 (ru) | 2009-09-10 |
| JP4820819B2 (ja) | 2011-11-24 |
| WO2006022762A1 (en) | 2006-03-02 |
| EP1791423B1 (en) | 2013-05-01 |
| CN101132693A (zh) | 2008-02-27 |
| EP1791423A1 (en) | 2007-06-06 |
| ZA200700694B (en) | 2007-11-28 |
| JP2008508354A (ja) | 2008-03-21 |
| PL1791423T3 (pl) | 2013-09-30 |
| ES2422893T3 (es) | 2013-09-16 |
| AU2004322710B2 (en) | 2011-03-31 |
| AU2004322710A1 (en) | 2006-03-02 |
| CN101132693B (zh) | 2012-11-07 |
| EP1791423A4 (en) | 2009-06-17 |
| PT1791423E (pt) | 2013-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200700694B (en) | Compositions and methods for the management of hyperproliferative dermatological conditions | |
| US8057825B2 (en) | Krill extracts for treatment of cardiovascular diseases | |
| Smith et al. | Complementary and alternative medicine for psoriasis: a qualitative review of the clinical trial literature | |
| EP3212288B1 (en) | Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract | |
| US7582314B2 (en) | Compositions and methods for the management of hyperproliferative dermatological conditions | |
| US20030185915A1 (en) | Synergetic composition for the treatment of psoriasis and other skin disorders and method therefor | |
| CA2408541C (en) | Treating eczema and/or psoriasis | |
| Dayanarayana et al. | Non surgical approaches in treatment of OSF | |
| US11590211B2 (en) | Systems for treating dermal inflammatory conditions | |
| US8147851B2 (en) | Treating eczema and/or psoriasis | |
| BEHANDLUNG et al. | DERMATOLOGICAL CONDITIONS | |
| EP1863493B1 (en) | Corticosteroid containing formulation for treating psoriasis, eczema, ulcer and burns. | |
| CN103816539B (zh) | 一种包含盐酸氨基乙酰丙酸的药物组合物 | |
| US20250186526A1 (en) | Healing creams and formulations containing pomegranate seed oil, rosa canina fruit oil, inula viscosa oleoresin or extract and optionally citrus medica vulgaris etrog oil or extract | |
| Yun | A Case of Improvement of Photosensitivity Allergy Using Ortho-Cellular Nutrition Therapy (OCNT) | |
| EP1688145A1 (en) | Methods and compositions for treating psoriasis | |
| WO2024173775A1 (en) | Dietary supplement for managing stress-induced inflammatory skin disorders | |
| Lieberman | Natural Interventions for Treating Psoriasis | |
| RU2171683C1 (ru) | Средство для лечения псориаза (варианты) и способ его лечения | |
| WO2014197129A2 (en) | Compositions and methods for treatment and management of pain | |
| WO2023247796A1 (en) | A skin care composition | |
| WO2006119540A1 (en) | Preparation for treating psoriasis | |
| Doddamani et al. | www. ijrap. net (ISSN: 2229–3566) | |
| HK1126957B (en) | Krill extracts for prevention and/or treatment of cardiovascular diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: SAMI LABS LTD., IN Free format text: OLD OWNER(S): MUHAMMED MAJEED; SUBBALAKAKSHMI PRAKASH |
|
| S883 | Correction of error according to section 88(3) (mistake in register caused on part of patentee or applicant) |
Free format text: THE INVENTORS (72) WERE THE ORIGINAL APPLICANTS AND SUBSEQUENTLY ASSIGNED THE PATENT TO THE CURRENT APPLICANT (71) |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 14 OCT 2017 BY KALYANAM NAGABHUSHANAM Effective date: 20140911 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2018 BY KALYANAM NAGABHUSHANAM Effective date: 20170920 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2019 BY KALYANAM NAGABHUSHANAM Effective date: 20181003 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2020 BY SABINSA Effective date: 20190821 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2021 BY SABINSA Effective date: 20201006 |
|
| LAPS | Patent lapsed |